These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 235560)

  • 1. NADPH oxidase deficiency in X-linked chronic granulomatous disease.
    Hohn DC; Lehrer RI
    J Clin Invest; 1975 Apr; 55(4):707-13. PubMed ID: 235560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deficiency of NADPH oxidase activity in chronic granulomatous disease.
    McPhail LC; DeChatelet LR; Shirley PS; Wilfert C; Johnston RB; McCall CE
    J Pediatr; 1977 Feb; 90(2):213-7. PubMed ID: 12254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydrogen peroxide production in chronic granulomatous disease. A cytochemical study of reduced pyridine nucleotide oxidases.
    Briggs RT; Karnovsky ML; Karnovsky MJ
    J Clin Invest; 1977 Jun; 59(6):1088-98. PubMed ID: 193872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic granulomatous disease. Molecular genetics.
    Dinauer MC; Orkin SH
    Hematol Oncol Clin North Am; 1988 Jun; 2(2):225-40. PubMed ID: 3292508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Editorial: Microbial killing by neutrophils.
    Lancet; 1976 Jun; 1(7974):1393-4. PubMed ID: 59024
    [No Abstract]   [Full Text] [Related]  

  • 6. Deficient flavoprotein component of the NADPH-dependent O2-.-generating oxidase in the neutrophils from three male patients with chronic granulomatous disease.
    Gabig TG; Lefker BA
    J Clin Invest; 1984 Mar; 73(3):701-5. PubMed ID: 6707199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of NADH and NADPH oxidase activities in granules isolated from human polymorphonuclear leukocytes with a fluorometric assay.
    Iverson D; DeChatelet LR; Spitznagel JK; Wang P
    J Clin Invest; 1977 Feb; 59(2):282-90. PubMed ID: 833275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic granulomatous disease.
    Schmalzer EA; Miller DR
    Prog Med Genet; 1976; 1():145-84. PubMed ID: 935507
    [No Abstract]   [Full Text] [Related]  

  • 9. Increased phagocytic activity of polymorphonuclear leukocytes of chronic granulomatous disease as determined with flow cytometric assay.
    Hasui M; Hirabayashi Y; Hattori K; Kobayashi Y
    J Lab Clin Med; 1991 Apr; 117(4):291-8. PubMed ID: 1849170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progress in gene therapy for chronic granulomatous disease.
    Malech HL
    J Infect Dis; 1999 Mar; 179 Suppl 2():S318-25. PubMed ID: 10081502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phosphoprotein of Mr 47,000, defective in autosomal chronic granulomatous disease, copurifies with one of two soluble components required for NADPH:O2 oxidoreductase activity in human neutrophils.
    Bolscher BG; van Zwieten R; Kramer IM; Weening RS; Verhoeven AJ; Roos D
    J Clin Invest; 1989 Mar; 83(3):757-63. PubMed ID: 2537848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular genetics of chronic granulomatous disease.
    Dinauer MC; Orkin SH
    Immunodefic Rev; 1988; 1(1):55-69. PubMed ID: 3078710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A point mutation in gp91-phox of cytochrome b558 of the human NADPH oxidase leading to defective translocation of the cytosolic proteins p47-phox and p67-phox.
    Leusen JH; de Boer M; Bolscher BG; Hilarius PM; Weening RS; Ochs HD; Roos D; Verhoeven AJ
    J Clin Invest; 1994 May; 93(5):2120-6. PubMed ID: 8182143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skewing of X-chromosome inactivation in three generations of carriers with X-linked chronic granulomatous disease within one family.
    Köker MY; Sanal O; de Boer M; Tezcan I; Metin A; Tan C; Ersoy F; Roos D
    Eur J Clin Invest; 2006 Apr; 36(4):257-64. PubMed ID: 16620288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Biological and clinical aspects of chronic granulomatous disease].
    Robak T; Robak E
    Przegl Lek; 1992; 49(5):168-71. PubMed ID: 1438921
    [No Abstract]   [Full Text] [Related]  

  • 16. [Chronic septic granulomatous disease in two brothers (author's transl)].
    Rister M; Fröhlich G; Seiferth J
    Dtsch Med Wochenschr; 1974 Oct; 99(43):2172-5. PubMed ID: 4154190
    [No Abstract]   [Full Text] [Related]  

  • 17. Analytical subcellular fractionation of neutrophils from patients with chronic granulomatous disease. Demonstration of the enzyme defect in four cases.
    Segal AW; Peters TJ
    Q J Med; 1978 Apr; 47(186):213-20. PubMed ID: 684156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic variants of chronic granulomatous disease: prevalence of deficiencies of two cytosolic components of the NADPH oxidase system.
    Clark RA; Malech HL; Gallin JI; Nunoi H; Volpp BD; Pearson DW; Nauseef WM; Curnutte JT
    N Engl J Med; 1989 Sep; 321(10):647-52. PubMed ID: 2770793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phagocytic NADPH oxidase and its role in chronic granulomatous disease.
    Pallister CJ; Hancock JT
    Br J Biomed Sci; 1995 Jun; 52(2):149-56. PubMed ID: 8520251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterisation of the enzyme defect in chronic granulomatous disease.
    Segal AW; Peters TJ
    Lancet; 1976 Jun; 1(7974):1363-5. PubMed ID: 59010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.